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Diabetic nephropathyTumor necrosis factor-α-inducible protein 8 (TNFAIP8) family are very recently identiﬁed proteins which
share considerable sequence homology to regulate cellular and immune homeostasis. However, it is
unknown whether TNFAIP8 family is expressed in the kidney and contributes to the regulation of renal
functions. Therefore, the present study was designed to characterize the members of TNFAIP8 family in the
kidney and to explore their possible roles in the development and progression of diabetic nephropathy. By
RT-PCR and Western blot analyses, we found that all members of TNFAIP8 family were detected in the
kidney. TNFAIP8 and TIPE2 expression was signiﬁcantly increased in glomeruli from streptozotocin (STZ)-
induced diabetic rats, and this upregulation was further conﬁrmed in renal biopsies of diabetic patients. In in
vitro study, TNFAIP8 was upregulated in response to high glucose in mesangial cells rather than podocytes.
Moreover, a direct correlation was observed between expression of TNFAIP8 and mesangial cell proliferation
and this regulation was associated with NADPH oxidase-mediated signaling pathway. However, we failed to
observe the upregulation of TIPE2 in both mesangial cells and podocytes in response to high glucose. In
conclusion, the present study addressed the role of TNFAIP8 family in diabetic nephropathy. These ﬁndings
for the ﬁrst time demonstrate that TNFAIP8 is one of critical components of a signal transduction pathway
that links mesangial cell proliferation to diabetic renal injury.y, Shandong University School
0012, P.R. China. Tel./fax: +86
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Diabetic nephropathy (DN) is one of the major microvascular
complications of diabetes and the most common cause of end stage of
renal diseases (ESRD) [1]. DN can be characterized by both glomerular
and tubulointerstitial injury. An important histological hallmark of DN
is mesangial cell proliferation, resulting in the expansion of
extracellular matrix (ECM) in the mesangium. Thickening of the
glomerular basement membrane (GBM) is another feature of DN [2].
Although the pathogenesis of DN is multifactorial, a number of clinical
and animal model studies have implicated inﬂammatory mechanisms
as important pathogenic factors in DN [3,4]. Inﬂammatory markers
such as IL-1β and TNF-α, are increased in the serum and tissues of
patients with DN. This occurs at a very early stage of disease, and
correlates with the degree of albuminuria. Inﬂammation is tradition-ally considered as a process resulting in macrophage inﬁltration.
However, current studies have also demonstrated that resident
glomerular cells such as mesangial cells and podocytes can produce
cytokines and express molecules that are part of the co-stimulatory
pathway [5]. These inﬂammatory cytokines and other mediators may
stimulate glomerular cells to enhance production or reduce degrada-
tion of ECM proteins [3,6]. Tumor necrosis factor-α-inducible protein
8 (TNFAIP8) family are very recently identiﬁed proteins and induced
by TNF-α stimulation and by activation of transcription factor NF-κB
[7,8], it is possible that this family may be the molecular link between
TNF-α-mediated signaling and DN.
TNFAIP8 family consists of TNFAIP8, TIPE1 (TNFAIP8L1, TNF-α-
induced protein 8-like 1), TIPE2 (TNFAIP8L2) and TIPE3 (TNFAIP8L3),
which share considerable sequence homology to regulate cell
functions [7,8]. TNFAIP8 (also called SCC-S2/GG2-1/NDED), the ﬁrst
identiﬁed member in this family, is associated with enhanced cell
survival and inhibition of apoptosis [9]. Overexpression of TNFAIP8
contributes to enhanced DNA synthesis, cell proliferation and
inhibition of activities of the apoptotic enzymes caspase 8 and caspase
3 [10]. Knocking down TNFAIP8 expression in tumor cells reduces
their tumorigenicity, suggesting that it may play a role in oncogenesis
Table 1
Primer pairs of rat TNFAIP8 family used for RT-PCR and real time RT-PCR in this study.
Genes Primers Product (bp)
TNFAIP8 F: 5'-CCCAGGGAAGTGGCTACAGA-3' 182
R: 5'-GCCTCCTTCTTGTTCTGGGT-3'
TIPE1 F: 5'-AGCAGAGGCACCTACAGAAA-3' 202
R: 5'-AAACTCCTTAGTGGCCTGGT-3'
TIPE2 F: 5'-TCAGAAACATCCAAGGCCAGAC-3' 147
R: 5'-CGGACCGACCAGCCATTTTAC-3'
TIPE3 F: 5'-ACTGCTGCAGGTCCTCATGT-3' 179
R: 5'-GCCTCCTTCTTGTTGTGGGT-3'
TNF-α F: 5'-CCACCACGCTCTTCTGTCTA-3' 163
R: 5'TTTGCTACGACGTGGGCTAC-3'
β-actin F: 5'-AGCCATGTACGTAGCCATCC-3' 115
R: 5'-ACCCTCATAGATGGGCACAG-3'
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pathways are intricately linked by TNFAIP8 [12]. However, the
physiological role of TNFAIP8 is not clear. In 2008, a second member
of TNFAIP8 family, designated TIPE2 (TNFAIP8L2) was identiﬁed as a
negative regulator to maintain immune homeostasis [8,13]. TIPE2
deletion in mice leads to multiorgan inﬂammation, splenomegaly,
and premature death. TIPE2 is preferentially expressed in lymphoid
tissues. Interestingly, although TIPE2 is not expressed in NIH 3T3
ﬁbroblasts cell line, following stimulation with TNF-α, NIH 3T3
ﬁbroblasts expressed detectable levels of TIPE2 mRNA, suggesting
that TIPE2 may be expressed in other cell types to establish
equilibrium during an inﬂammatory response. Besides TNFAIP8 and
TIPE2, two additional uncharacterized members of this family may
exist, which share high degrees of sequence homology with TIPE2 and
are designated as TTIPE1 and TIPE3 in the gene bank [8]. However, so
far it is unknown whether these four members of TNFAIP8 family are
expressed in the kidney and further contribute to the regulation of
renal functions in DN. Therefore, the present study was designed to
characterize TNFAIP8 family in the kidney and renal cells and further
to explore the possible roles in the development and progression of
DN.
2. Methods
2.1. Animal studies
Male Sprague–Dawley rats (150–170 g) were purchased from
Laboratory Animals Center of Shandong University, China. Diabetes
was induced by tail-vein injection of streptozotocin (STZ) at 50 mg/kg
body wt in sodium citrate buffer (0.01 M, pH 4.5). An equivalent
amount of sodium citrate buffer alone was used as a vehicle control.
Blood glucose levels were monitored 48 h later and periodically
thereafter (LifeScan One Touch glucometer, Johnson & Johnson,
Milpitas, CA, USA) by rat-tailed blood sampling. Rats with blood
glucose levels above 18.0 mMwere considered as diabetic. All rats had
unrestricted access to food/water and were maintained for 12 weeks
in accordance with Institutional Animal Care and Use Committee
procedures of Shandong University. Rats were weighed weekly and
blood pressure was determined by tail cuff plethysmography
(Harvard Apparatus, Holliston, MA, USA) monthly. At the end of the
study, weight, blood pressure and blood glucose were measured.
Urine was collected for 24 h in a metabolic cage and urinary albumin
excretion was measured using a rat albumin ELISA quantitation kit
(Bethyl Laboratories, Montgomery, TX, USA). Simultaneously, rats
were killed under ketamine anesthesia. The ﬁxed kidneys were
parafﬁn-embedded, and sections were prepared and stained with
periodic acid–Schiff stain. Glomerular damage index was calculated
from 0 to 4 on the basis of the degree of glomerulosclerosis and
mesangial matrix expansion as our previous studies [14]. Glomeruli
from the remainder of the kidney cortex were harvested by
differential sieving [15]. They were homogenized in lysis buffer or
Trizol for immunoblotting and mRNA analysis, respectively.
2.2. Human renal biopsy samples and Immunohistochemical studies
Renal biopsies had been performed as part of routine clinical
diagnostic investigation. Informed consent was obtained from
patients for use of archived human biopsy material and chart review
in accord with institutional research ethics board review. The patient
samples were obtained from Department of Pathology, Shandong
University School of Medicine with documented a pathologic
diagnosis of DN. Immunohistochemistry studies were performed
from an independent cohort of control subjects (histologically veriﬁed
unaffected regions from tumor nephrectomies) and DN case subjects.
TNFAIP8 and TIPE2 staining were used as a primary polyclonal
antibody at 1:150 (ProteinTech Group, Chicago, IL, USA) in this study.2.3. Cell culture
Rat renal mesangial cells were cultured in DMEM supplemented
with 10% FCS (Invitrogen, Gaithersburg, MD, USA), streptomycin
(100 μg/ml), and penicillin (100 U/ml) at 37 °C in 95% air/5% CO2.
Medium contained 5.6 mM glucose (Control group). To study the
effect of high glucose (HG), D-glucose at a ﬁnal concentration of 10, 20,
or 40 mM (4.4, 10.4, or 34.4 mM D-glucose was added in the medium
for HG condition) were employed in this study and mannitol was
added in the medium as the osmolarity control.
A clonal cell line of conditionally-immortalized murine podo-
cytes was the generous gift from Prof. Pin-Lan Li at Department of
Pharmacology, Virginia Commonwealth University, USA. Podocytes
were cultured as our previous studies [16]. Treatments of
podocytes with high glucose were similar as mesangial cell's
treatments.
2.4. RNA extraction and RT-PCR
Total RNA was isolated from renal glomeruli or cells using TRIzol
reagent (Invitrogen) as we described previously [16]. The mRNA
levels for target genes were analyzed by RT-PCR or real-time
quantitative RT-PCR using a Bio-Rad iCycler system (Bio-Rad,
Hercules, CA, USA). The speciﬁc primers for target genes used for
both RT-PCR and real-time quantitative RT-PCR are list in Table 1.
Levels of the housekeeping gene β-actin were used as an internal
control for the normalization of RNA quantity and quality differences
among the samples.
2.5. Western blot analysis
Western blotting was performed as we described previously [17].
Primary antibodies anti-TNFAIP8, anti-TIPE2 (1:1000 dilution, Pro-
teinTech Group) and secondly antibodies horseradish peroxidase-
labeled anti-mouse IgG or anti-rabbit IgG (1:6000 dilution) were used
in this study. To document the loading controls, the membrane was
reprobed with a primary antibody against housekeeping protein
β-actin.
2.6. RNA interference
Small interference RNA to TNFAIP8 (siRNA-TNFAIP8) was synthe-
sized by Biomics Biotechnologies Co., Ltd. (Nantong, Jiangsu, China).
The DNA target sequence for siRNA-TNFAIP8 (5'-CCA GCA GCG AGG
TCC TGG ATG AGC T-3') was designed based on the core sequence of
rat TNFAIP8 cDNA (Accession number NM_001107387). The scram-
bled small RNA (5'-AAT TCT CGA ACT GTC ACG T-3') has been
conﬁrmed as non-silencing double stranded RNA and was used as
control. In these experiments, siRNA transfection was performed
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Lipid transfection kit.2.7. Cell proliferation
Colorimetric assay were used in the assessment of cell prolifera-
tion. Cell proliferation was measured by DNA content using a
colorimetric assay as described [18]. Cells were grown in normal or
high glucose medium for 48 h. After washing the cells with ice cold
Hank's balanced salt solution. DNA was precipitated with 10%
trichloroacetic acid for 10 min at 4 °C, and 0.5 ml of a solution
containing 20 volumes of a stock (1 g of diphenylamine, 90 ml of
glacial acetic acid and 2 ml of sulfuric acid), 8 volumes of H2O and 0.1
volume of 1% acetaldehyde was added to each well for 48 h. DNA
content was determined in triplicate wells by reading OD 580 nm and
comparing to a standard curve established with calf thymus DNA. Cell
viability was determined at the end of treatments by trypan blue dye
exclusion method.2.8. Measurements of NADPH oxidase activity
NADPH oxidase activity was determined by measurement of O2⋅−
production in isolated glomeruli or cell homogenates. Fluorescence
spectrometry for O2⋅− production was performed by using a modiﬁed
DHE ﬂuorescent spectrometric assay as described previously [17].2.9. Statistics
Data are expressed as means±SE. The signiﬁcance of the
differences in mean values between and within multiple groups was
examined by one-way ANOVA followed by Duncan's multiple range
test. Pb0.05 was considered statistically signiﬁcant.Fig. 1. Expression patterns of TNFAIP8 family. (A) RT-PCR analysis of TNFAIP8 family in sele
(B) Summarized data showing the relative expression levels of TNFAIP8 family in tissues
TNFAIP8 family in glomerular cells by real time RT-PCR (n=5).3. Results
3.1. Expression of TNFAIP8 family in the kidney and renal cells
To determine the expression patterns of TNFAIP8 family, total RNA
was extracted from tissues of Sprague-Dawley rats and RT-PCR was
performed. As shown in Fig. 1A, among kidney, brain, liver and spleen,
TNFAIP8 was the most abundant in the kidney, whereas it was hard to
detect in the liver. TIPE1 was detected in these tissues with relative
high levels in the spleen and liver. TIPE2 was rich in spleen and brain,
whereas expression level in the kidney was very low. TIPE3 was
detected in brain and kidney. We further determined the expression
levels of TNFAIP8 family in glomerular cells including mesangial cells
and podocytes by real time RT-PCR analysis. We found that four
members of the TNFAIP8 family were present in these cell lines. TIPE1
and TNFAIP8 were widely expressed; TIPE3 was preferentially
expressed in mesangial cells; TIPE2 was very low expressed in both
mesangial cells and podocytes. Fig. 1B and C are summarized data
showing the distributions of TNFAIP8 family in tissues and some
glomerular cells, respectively.
3.2. Renal function changes in experimental diabetic rats
As shown in Table 2, diabetic rats had hyperglycemia, lower body
weight than their non-diabetic counterparts. No difference in blood
pressure was observed between these groups. Glomerular damages
by morphological analysis (Fig. 2A) and increased urinary albumin
excretion were observed in the diabetic rats (Fig. 2B). In addition, the
cytokine TNF-α and NADPH oxidase-mediated oxidative stress have
also been implicated in the pathogenesis of DN. Therefore, we further
measured glomerular mRNA level of TNF-α and NADPH oxidase
activity. It was found that the TNF-α level was 2.1-fold higher than in
that of non-diabetic rats (Fig. 2C). NADPH oxidase activity was
signiﬁcantly increased in glomeruli from diabetic rats (Fig. 2D).cted tissues and glomerular cells including renal mesangial cells (RMC) and podocytes.
by real time RT-PCR. (C) Summarized data showing the relative expression levels of
Table 2
Clinical characteristics of control and STZ-induced diabetic rats. Data were expressed as
means±SE. control=control rats, STZ=STZ-induced diabetic rats. Pb0.05 was
considered statistically signiﬁcant.
Control STZ p
Glucose (mM) 5.59±0.37 22.18±2.16 b 0.05
Body weight (g) 488.2±41.6 319.7±22.1 b 0.05
Systolic blood pressure (mm Hg) 108.5±3.41 112.1±4.24 N
Urine volume (ml/day) 18.28±4.68 137.3±22.92 b 0.05
n 12 12
1081S. Zhang et al. / Biochimica et Biophysica Acta 1802 (2010) 1078–10863.3. Enhanced TNFAIP8 and TIPE2 expression in the glomeruli fromdiabetic
rats and patients with DN
By real time RT-PCR analysis, we found that, among the TNFAIP8
family, TNFAIP8 and TIPE2 mRNA levels were markedly enhanced in
glomeruli isolated from diabetic rats. Both TIPE1 and TIPE3 mRNA levels
had no signiﬁcant difference compared with those from normal rats
(Fig. 3A).We then assessed glomerular TNFAIP8 and TIPE2 protein levels
in diabetic rats. Consistent with the changes in mRNA levels, both
TNFAIP8 and TIPE2 protein levels were signiﬁcantly increased (Fig. 3B).
By immunochemical analysis, we further observed that TNFAIP8 was
mainly expressed in mesangium of glomeruli from diabetic rats. TIPE2
was relatively widely expressed in the glomeruli and renal interstitium
from diabetic rats (Fig. 3C). Finally, by real time RT-PCR and immuno-
chemical analyses of human renal biopsy samples, we also conﬁrmed the
upregulation of TNFAIP8 and TIPE2 in the kidney (Fig. 3D and E).
3.4. TNFAIP8 upregulation in response to high glucose in mesangial cells
rather than podocytes
Two cells lines including mesangial cells and podocytes which
mainly contribute to glomerulosclerosis were selected to investigatecontrol DN
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Fig. 2. Characterization of rat glomerular injury and related signaling molecules in s
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(B) Urinary albumin excretion from different groups of rats. (C) Relative mRNA levels of TNF
oxidase activity in glomeruli from different groups of rats. *Pb0.05 compared with controlthe changes of TNAFAIP8 and TIPE2 in response to high glucose in
vitro. As shown in Fig. 4A, we found that D-glucose concentration
dependently enhanced TNFAIP8 levels in mesangial cells with a 260%
increase at a ﬁnal glucose concentration of 40 mM. To ensure these
effects were not osmotically mediated, we incubated mesangial cells
with equivalent concentrations of mannitol, no effects on TNFAIP8
expression level. In mesangial cells treated with TNF-α (10 to 50 ng/
mL), as documented in Fig. 4B, TNF-α increased TNFAIP8 expression
in mesangial cells. However, when podocytes were exposed to the
same concentrations of high glucose, TNFAIP8 expression levels had
no changes (Fig. 4C), suggesting that TNFAIP8 may mainly act on
mesangial cells and regulate their functions.
Next, we detected the TIPE2 expression under high glucose
conditions in both mesangial cells and podocytes. Interestingly, TIPE2
was not upregulated in either mesangial cells or podocytes (data not
shown).
3.5. Regulation of TNFAIP8 expression is associated with NADPH oxidase
activity
Given the role of NADPH oxidase-mediated NF-κB activity and the
fact that TNFAIP8 can be induced by NF-κB, we wondered whether
NADPH oxidase activity is associated with the upregulation of TNFAIP8
inhigh glucose-treatedmesangial cells. Therefore, the activity ofNADPH
oxidase was measured by ﬂuorescence spectrometric assay. Summa-
rized data showed that NADPH oxidase activity was increased by high
glucose treatment in a concentration dependent manner, which was
blocked by NADPH oxidase inhibitor apocynin (Fig. 5A and B). We
further found that both high glucose and TNF-α induced TNFAIP8
expression in mesangial cells, which was attenuated by inhibition of
NADPH oxidase activity as shown in Fig. 5C and D.
Gene silencing of TNFAIP8 attenuated high glucose-induced
mesangial cell proliferation: To investigate the role of TNFAIP8 onControl
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amage index (GDI) by semiquantitation of scores in control and diabetic rats (DN).
-α by real-time RT-PCR analysis in glomeruli from different groups of rats. (D) NADPH
(n=9).
Fig. 3. The expression levels of TNFAIP8 family in glomeruli from diabetic rats. (A) Relative quantitation of mRNA levels in TNFAIP8 family by real-time RT-PCR analysis in glomeruli
from different groups. (B) Representative Western blot gel document showing the protein levels of TNFAIP8 and TIPE2 in glomeruli. (C) Immunohistochemistry for TNFAIP8 and
TIPE2 in the kidney from diabetic rats. TNFAIP8 and TIPE2 expression (brown) were observed in diabetic rats. (D) Relative quantitation of mRNA levels in TNFAIP8 family by real-
time RT-PCR analysis in human renal biopsy samples. (E) Immunohistochemistry for TNFAIP8 and TIPE2 in human renal biopsy samples. TNFAIP8 and TIPE2 expression (brown)
were observed in the kidney from diabetic patients (n=18) *Pb0.05 compared with control (n=18).
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Fig. 4. Effects of high glucose (HG) on the expression of TNFAIP8 in different glomerular cells. (A) Representative Western blot gel documents of TNFAIP expression (left panel) and
summarized data showing TNFAIP8 protein levels in response to high glucose in mesangial cells. (B) Representative Western blot gel documents of TNFAIP8 expression (left panel)
and summarized data showing TNFAIP8 protein levels in response to TNF-α in mesangial cells. (C) Representative Western blot gel documents of TNFAIP8 expression (left panel)
and summarized data showing TNFAIP8 protein levels in response to high glucose in podocytes. *Pb0.05 vs. control (n=6).
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TNFAIP8 gene silencing by siRNA was used in this study. By real-time
RT-PCR and Western blot analyses, TNFAIP8 mRNA and protein levels
were decreased by 76% and 61 % in siRNA-TNFAIP8 transfected
mesangial cells, respectively (Fig. 6A and B). This siRNA- TNFAIP8 had
no effect on other members of TNFAIP family expression levels,
indicating the speciﬁcity of siRNA to TNFAIP8 (data not shown). Then,
we determined the effect of siRNA-TNFAIP8 on mesangial cell
proliferation. It was found that high glucose signiﬁcantly increased
mesangial cell proliferation, which was markedly blocked by siRNA-
TNFAIP8 or apocynin indicating that TNFAIP8 contributes to high
glucose-induced mesangial cell proliferation (Fig. 6C and D). Similar
results were also obtained in mesangial cells treated with TNF-α
(25 ng/ml) (Fig. S1).
4. Discussion
This is the ﬁrst report to characterize TNFAIP8 family in the kidney
and investigate their potential roles in DN.We found that, among fourmembers of this family, TNFAIP8 and TIPE2 were upregulated in DN,
indicating that they may participate in the pathogenesis of DN. A
direct correlation was observed between expression of TNFAIP8 and
cell proliferation in high glucose-treated mesangial cells. We further
demonstrated that this regulation is associated with NADPH oxidase-
mediated signaling pathways. In combination with clinical data,
formalin-ﬁxed, parafﬁn-embedded human kidney tissues provide
important information of TNFAIP8 family in the pathogenesis of DN.
A subfamily of proteins that contribute to cellular homeostasis
possesses a hexahelical bundlemotif, called the death effector domain
(DED) [19]. Both pro- and anti-apoptotic proteins containing DEDs
have been identiﬁed. For Fas and other death receptors, homotypic
DED interactions connect the Fas-associated death domain (FADD)
protein to caspase-8 and caspase-10 to mediate the formation of the
death-inducing signal complex (DISC), thereby initiating apoptosis
[19,20]. This complex can be inhibited by other DED-containing pro-
teins. Accumulating evidence suggests that DED-containing proteins
also play a role in controlling pathways of cellular activation and
proliferation [19,21,22]. Cellular and viral antiapoptotic DED proteins,
Fig. 5. Effects of NADPH oxidase activity on the expression of TNFAIP8 in mesangial cells. (A) Summarized data showing NADPH oxidase activity in mesangial cells treated with
different glucose concentrations. (B) Summarized data showing the effect of NADPH oxidase inhibitor apocynin on NADPH oxidase activity in high glucose-treated mesangial cells.
(C) Summarized data showing the effect of apocynin on the expression of TNFAIP8 in high glucose-treated mesangial cells. (D) Summarized data showing the effect of apocynin on
the expression of TNFAIP8 in TNF-α-treated mesangial cells. *Pb0.05 vs. control, #Pb0.05 vs. vehicle of high glucose or TNF-α treatment (n=6).
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and caspase-8 [23,24]. A DED-containing protein PEA-15 inhibits
apoptosis induced by Fas in astrocytes and some tumor cells [25]. In
addition, overexpression of PEA-15 activates ERK and stimulates
proliferation in vitro in a Ras-dependent manner [26]. Thus, the DED
proteins may be pivotal to cellular homeostasis by establishing a “cell
renewal set point” that coregulates proliferation and apoptosis in
parallel [19]. TNFAIP8 family is normally considered as a new
subfamily of DED containing proteins by sequence analysis showing
the high sequence homology with DED and experimental evidence
showing the regulatory role of apoptosis. However, the high-
resolution crystal structure of TIPE2 reveals a previously uncharacter-
ized fold different from the predicted fold of a DED [13]. Strikingly,
TIPE2 contains a notable feature-a large, hydrophobic central cavity
that is poised for cofactor binding [13]. Therefore, it was proposed that
the central cavity may have an important role in the maintenance
of immune homeostasis by binding to a cofactor. Hence, considering
the high degree of sequence conservation among TNFAIP8 family,
TNFAIP8 family may represent a novel class of molecules that main-
tain immune and cellular homeostasis through a previously unchar-
acterized mechanism.
In the present study, our major aim is to investigate whether
TNFAIP8 family is associated with DN. We ﬁrst determined the
expression proﬁle of TNFAIP8 family in the rat kidney. By mRNA and
Western blot analyses, all members of TNFAIP8 family are detected inthe kidney, although the TIPE2 expression level is very low. One of the
most important ﬁndings of this study is that both TNFAIP8 and TIPE2
levels are markedly increased in glomeruli from diabetic rats and
diabetic patients, indicating that TNFAIP8 and TIPE2 may play
important roles in the development of glomerulosclerosis in DN.
In this study, two cells lines includingmesangial cells and podocytes
which mainly contribute to glomerulosclerosis were selected in in vitro
study. Asweknow, among the pathological changes of DN, uncontrolled
mesangial cell proliferation is correlated closely with progression of
renal failure, which causes an increase in extracellular matrix (ECM)
deposition and ultimately leads to glomerulosclerosis [1,27]. In renal
diseases, both resident renal cells and inﬁltrating immune cells such as
macrophages are capable of secreting pro-inﬂammatory cytokines
including IL-1β and TNF-α [28]. These cytokines may initially serve to
sustain the inﬂammatory process, thereby promoting ongoing mesan-
gial cell proliferation and ECM production, leading to the progressive
glomerular injury in DN. Hence, we further investigated whether
hyperglycemia regulates TNFAIP8 expression and whether TNFAIP8-
related signaling is involved in the regulation of mesangial cell
proliferation. We found that, in response to high glucose, TNFAIP8
expression was signiﬁcantly enhanced in mesangial cells and this
increase in TNFAIP8 expression contributed to mesangial cell prolifer-
ation. Our results are consistent with previous studies indicating
that TNFAIP8 is associated with enhanced cell survival and inhibition
of apoptosis [9,12]. However, a very recent report showed that
Fig. 6. Effects of TNFAIP8 on mesangial cell proliferation. (A) Quantitative RT-PCR analysis of TNFAIP8 mRNA levels in control, scrambled RNA and siRNA-TNFAIP8 transfected
mesangial cells. (B) Representative Western blot gel documents (upper panel) and summarized data showing relative of TNFAIP8 protein levels in the homogenate from transfected
mesangial cells. (C) Summarized data showing cell proliferation evaluated by the assessment of DNA content. (D) Summarized data showing cell proliferation evaluated by the
assessment of cell number. *Pb0.05 vs. control, #Pb0.05 vs. vehicle of high glucose treatment (n=6).
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thymocytes against glucocorticoid-induced apoptosis, suggesting that
TNFAIP8 is crucial in regulating glucocorticoid-mediated apoptosis of
thymocytes [30]. Therefore, it is necessary to further investigate the
regulatory role of TNFAIP8 on cell survival and apoptosis, which may
provide unusual insights into the mechanisms of maintaining cellular
homeostasis. Recent studies have also correlated podocyte loss with the
onset and magnitude of glomerulosclerosis [29,30]. We then detected
the TNFAIP8 expression in podocytes. However, therewas no signiﬁcant
difference on TNFAIP8 expression in podocytes with or without high
glucose treatment, indicating that TNFAIP8 may mainly act on
mesangial cells and regulate their functions.
A number of reports have indicated that NADPH oxidase-derived
reactive oxygen species (ROS) is central to hyperglycaemia-induced
oxidative stress in DN [31,32]. NADPH oxidase subunit Nox 4 appears
to be the predominant isoform expressed in renal cells. Increases in
Nox 4 mRNA levels were detected in the kidney of diabetic rats 4–
8 weeks after the onset of diabetes with similar increases detected in
mesangial cells exposed to high glucose [33,34]. Therefore, it is
imperative to know whether the regulation of TNFAIP8 expression is
associated with NADPH oxidase activity. Our results showed that
NADPH oxidase inhibitor apocynin attenuated high glucose or TNF-α-
induced TNFAIP8 expression. Furthermore, we found that both
apocynin and gene silencing of TNFAIP8 inhibited high glucose- and
TNF-α-induced increase in mesangial cell proliferation. Since TNF-α
can increase ROS production through c-Src/NADPH oxidase, in turninitiates the activation of NF-κB [35], it is possible that high glucose-
induced TNF-α may stimulate NADPH oxidase, thereby leads to
activation of NF-κB pathway, ﬁnally resulting in the upregulation of
TNFAIP8.
Next, we detected the TIPE2 expression under high glucose
conditions in both mesangial cells and podocytes. We failed to observe
the upregulation of TIPE2 in both mesangial cells and podocytes, which
is controversial with our in vivo study showing that the expression of
TIPE2 was signiﬁcantly increased in glomeruli from diabetes. As we
know, inﬁltration of immune cells plays an important role in the
development and progression of DN [36]. Macrophage is one of the
central mediators of renal vascular inﬂammation, and its accumulation
is a characteristic feature of diabetic nephropathy [37]. Therefore, it is
possible that this upregulation of TIPE2 is likely expressed by inﬁltrating
macrophages. Therefore, continuous slices of human renal biopsy
samples were stained with CD68 (one marker of macrophage) and
TIPE2 individually. We observed that CD68-positive inﬁltrating macro-
phages in the interstitium and glomeruli, which are colocalized with
TIPE2 (Fig. S2). These results indicate that inﬁltrating macrophages
contribute to, at least in part to the upregulation of TIPE2 expression in
the kidney. However, we also found that TIPE2 was induced in other
area. Therefore,we cannot exclude that someunknownmechanismsare
involved in the regulation of TIPE2 expression acting on the renal
resident cells in vivo. This regulationmay be a complex network, further
studies need to beaddressed this issue. In addition, our researchgroup is
investigating the functional relevance of TIPE2 in DN using TIPE2
1086 S. Zhang et al. / Biochimica et Biophysica Acta 1802 (2010) 1078–1086knockout mice, which are kindly gifts from Dr. Youhai Chen,
Department of Pathology and Laboratory Medicine, University of
Pennsylvania, USA.
In summary, the present study addressed the role of TNFAIP8
family in DN. These ﬁndings for the ﬁrst time demonstrate that
TNFAIP8 is one of critical components of a signal transduction
pathway that links mesangial cell proliferation to diabetic renal
injury. Pharmacological targeting of this pathway at multiple levels
may provide a novel approach to treatment of diabetic renal disease.
Despite many investigators have been able to inhibit mesangial cell
proliferation both in vitro and in vivo using different strategies, most of
patients and experimental animal models continue to show progres-
sive renal damage. It would be desirable to inhibit mechanisms that
are unique to proliferating mesangial cells to avoid effects on other
actively dividing cells. Therefore, TNFAIP8-inhibiting may provide
promising new strategies in the treatment of mesangial proliferative
renal diseases. Regarding this issue, current investigations in our
laboratory are designed to use structure-based virtual screening to
obtain potent inhibitors of TNFAIP8 and examine their effects in
treatment of DN.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbadis.2010.08.003.
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